CanSino Biologics is a Chinese pharmaceutical company with close ties to the Chinese Communist Party. The co-founders, CEO Dr. Xuefeng Yu and executive director Dr. Tao Zhu, are both members of the “Thousand Talents Plan”, a Chinese Communist Party recruiting strategy.
Earlier in 2020, the Trudeau government signed a contract with the Chinese pharmaceutical company. Members of the Liberal Party denied the existence of the contract, but documents provided by the Access To Information Act showed a contract clearly existed.
Moreover, the contract included a provision by which the Trudeau government gave a non-refundable cash advance to CanSino, despite the Chinese firm never delivering any of its ineffective vaccines to Canada.
According to experts, the Trudeau government’s decision to strike a deal with a company close to the CCP was nonsensical and resulted in a lagging vaccination campaign.
The cost of the non-refundable “fee” has not been revealed. Canada never received a single dose from CanSino Biologics, whose vaccine is considered amongst the least effective at preventing COVID-19.